Home » Topics » Immune, BioWorld Science

Immune, BioWorld Science
RSS

Glaxo Wellcome and PowderJect expand DNA vaccine collaboration

Jan. 25, 1999

Alpha-Beta Technology discontinues phase III trial of Betafectin

Jan. 25, 1999

Cel-Sci and University of Maryland receive award for TB vaccine development

Jan. 22, 1999

Terprenin: novel immunosuppressant and antiallergic substance under evaluation at Shionogi

Jan. 22, 1999

Antex Biologics receives milestone payment from Pasteur Merieux Connaught

Jan. 21, 1999

FDA committee does not recommend approval of Prograf for GVHD

Jan. 21, 1999

Global FluMist collaboration announced by Aviron and Wyeth Lederle Vaccines

Jan. 14, 1999

Licensing opportunity from RCT: VZV subunit vaccine

Jan. 14, 1999

First vaccine for Lyme disease now available from SB in the U.S.

Jan. 13, 1999

Licensing opportunity from Peptech: anti-TNF antibodies with a range of therapeutic applications

Jan. 13, 1999

Popular Stories

Today's news in brief
BioWorld
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...